Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr 1;80(4):342-351.
doi: 10.1001/jamaneurol.2023.0033.

Optimal Intensity and Duration of Walking Rehabilitation in Patients With Chronic Stroke: A Randomized Clinical Trial

Affiliations

Optimal Intensity and Duration of Walking Rehabilitation in Patients With Chronic Stroke: A Randomized Clinical Trial

Pierce Boyne et al. JAMA Neurol. .

Abstract

Importance: For walking rehabilitation after stroke, training intensity and duration are critical dosing parameters that lack optimization.

Objective: To assess the optimal training intensity (vigorous vs moderate) and minimum training duration (4, 8, or 12 weeks) needed to maximize immediate improvement in walking capacity in patients with chronic stroke.

Design, setting, and participants: This multicenter randomized clinical trial using an intent-to-treat analysis was conducted from January 2019 to April 2022 at rehabilitation and exercise research laboratories. Survivors of a single stroke who were aged 40 to 80 years and had persistent walking limitations 6 months or more after the stroke were enrolled.

Interventions: Participants were randomized 1:1 to high-intensity interval training (HIIT) or moderate-intensity aerobic training (MAT), each involving 45 minutes of walking practice 3 times per week for 12 weeks. The HIIT protocol used repeated 30-second bursts of walking at maximum safe speed, alternated with 30- to 60-second rest periods, targeting a mean aerobic intensity above 60% of the heart rate reserve (HRR). The MAT protocol used continuous walking with speed adjusted to maintain an initial target of 40% of the HRR, progressing up to 60% of the HRR as tolerated.

Main outcomes and measures: The main outcome was 6-minute walk test distance. Outcomes were assessed by blinded raters after 4, 8, and 12 weeks of training.

Results: Of 55 participants (mean [SD] age, 63 [10] years; 36 male [65.5%]), 27 were randomized to HIIT and 28 to MAT. The mean (SD) time since stroke was 2.5 (1.3) years, and mean (SD) 6-minute walk test distance at baseline was 239 (132) m. Participants attended 1675 of 1980 planned treatment visits (84.6%) and 197 of 220 planned testing visits (89.5%). No serious adverse events related to study procedures occurred. Groups had similar 6-minute walk test distance changes after 4 weeks (HIIT, 27 m [95% CI, 6-48 m]; MAT, 12 m [95% CI, -9 to 33 m]; mean difference, 15 m [95% CI, -13 to 42 m]; P = .28), but HIIT elicited greater gains after 8 weeks (58 m [95% CI, 39-76 m] vs 29 m [95% CI, 9-48 m]; mean difference, 29 m [95% CI, 5-54 m]; P = .02) and 12 weeks (71 m [95% CI, 49-94 m] vs 27 m [95% CI, 3-50 m]; mean difference, 44 m [95% CI, 14-74 m]; P = .005) of training; HIIT also showed greater improvements than MAT on some secondary measures of gait speed and fatigue.

Conclusions and relevance: These findings show proof of concept that vigorous training intensity is a critical dosing parameter for walking rehabilitation. In patients with chronic stroke, vigorous walking exercise produced significant and meaningful gains in walking capacity with only 4 weeks of training, but at least 12 weeks were needed to maximize immediate gains.

Trial registration: ClinicalTrials.gov Identifier: NCT03760016.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Boyne reported receiving grants from the National Institutes of Health (NIH) during the conduct of the study. Dr Reisman reported receiving grants from the NIH during the conduct of the study. Ms Burson reported receiving grants from the NIH during the conduct of the study. Dr Kissela reported receiving grants from the National Institute of Neurological Disorders and Stroke, NIH during the conduct of the study. Dr Miller reported receiving grants from the Foundation for Physical Therapy Research and the University of Delaware Foundation during the conduct of the study. Dr Sucharew reported receiving grants from the NIH during the conduct of the study. Dr Thompson reported receiving grants from the University of Delaware and a subaward of a primary NIH grant to the University of Cincinnati during the conduct of the study. Dr Whitaker reported receiving grants from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH during the conduct of the study. Dr Dunning reported receiving grants from the NIH during the conduct of the study. No other disclosures were reported.

Figures

Figure 1.
Figure 1.. CONSORT Flow Diagram
AE indicates adverse event; HIIT, high-intensity interval training; and MAT, moderate-intensity aerobic training. aPrior myocardial infarction with peri-infarct ischemia on most recent perfusion scan. bFlare-ups of preexisting back pain. cRecurring hamstring strain or soreness.
Figure 2.
Figure 2.. Treatment Intensity
Values are model estimates for each bout of each session, averaging data across participants. Filled circles indicate overground 1; open circles, overground 2; and crosses, treadmill. A, Speed data are peak values within a bout. B, Steady state mean heart rate (HR) excludes the first 3 minutes of the bout. For treatment monitoring, the percentage of HR reserve (HRR) was relative to the standing resting HR and the most current peak HR, which could increase after sessions 12 and 24. Shading indicates aerobic intensity zones: orange, moderate; gray, vigorous. HIIT indicates high-intensity interval training; MAT, moderate-intensity interval training.
Figure 3.
Figure 3.. Primary Outcome of 6-Minute Walk Test Changes During 12 Weeks of High-intensity Interval Training (HIIT) or Moderate-intensity Aerobic Training (MAT) in Patients With Chronic Stroke
Values are model estimates; error bars, 95% CIs; and shading, clinically important difference in distance (20-50 m). aP < .05 for the false discovery rate in between-group differences in change from baseline. bP < .05 for within-group change from baseline. cP < .05 for within-group change between consecutive time points.

Comment in

References

    1. Mayo NE, Wood-Dauphinee S, Côté R, Durcan L, Carlton J. Activity, participation, and quality of life 6 months poststroke. Arch Phys Med Rehabil. 2002;83(8):1035-1042. doi:10.1053/apmr.2002.33984 - DOI - PubMed
    1. Rudberg AS, Berge E, Laska AC, et al. . Stroke survivors’ priorities for research related to life after stroke. Top Stroke Rehabil. 2021;28(2):153-158. doi:10.1080/10749357.2020.1789829 - DOI - PubMed
    1. Billinger SA, Arena R, Bernhardt J, et al. ; American Heart Association Stroke Council; Council on Cardiovascular and Stroke Nursing; Council on Lifestyle and Cardiometabolic Health; Council on Epidemiology and Prevention; Council on Clinical Cardiology . Physical activity and exercise recommendations for stroke survivors: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45(8):2532-2553. doi:10.1161/STR.0000000000000022 - DOI - PubMed
    1. Winstein CJ, Stein J, Arena R, et al. ; American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; Council on Quality of Care and Outcomes Research . Guidelines for adult stroke rehabilitation and recovery: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2016;47(6):e98-e169. doi:10.1161/STR.0000000000000098 - DOI - PubMed
    1. Hornby TG, Reisman DS, Ward IG, et al. ; Locomotor CPG Appraisal Team . Clinical practice guideline to improve locomotor function following chronic stroke, incomplete spinal cord injury, and brain injury. J Neurol Phys Ther. 2020;44(1):49-100. doi:10.1097/NPT.0000000000000303 - DOI - PubMed

Publication types

Associated data